Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Keller Benvenutti Kim (KBK) is a boutique law firm based in San Francisco that specializes in corporate restructuring, insolvency, and complex business litigation. While not a biotechnology or healthcare company itself, KBK is a prominent service provider within the life sciences ecosystem, often representing distressed biotech and pharmaceutical firms in Chapter 11 bankruptcy proceedings and out-of-court reorganizations. The firm is well-regarded for its expertise in navigating the unique financial and intellectual property challenges faced by venture-backed and public technology companies. Notable engagements include the representation of Clovis Oncology during its high-profile restructuring. KBK provides strategic legal counsel to boards of directors and management teams facing insolvency or financial distress.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Keller Benvenutti Kim.